Evidence map›Paper›PMID 26379698›Full record

ArticleFrontiers in genetics2015

A porcine model system of BRCA1 driven breast cancer.

Howard Donninger, Katharine Hobbing, M L Schmidt, Eric Walters, Laurie Rund, Larry Schook, Geoffrey J Clark

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Swine models for translational oncological research: an evolving landscape and regulatory considerations.Mammalian genome : official journal of the International Mammalian Genome Society · 2022
    Review
  5. Large Animal Models of Breast Cancer.Frontiers in oncology · 2022
    Review
  6. Application of the transgenic pig model in biomedical research: A review.Frontiers in cell and developmental biology · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Genetically Engineered Pigs to Study Cancer.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Howard DonningerDepartment of Medicine, James Graham Brown Cancer Center, University of Louisville Louisville, KY, USA.
Katharine HobbingDepartment of Pharmacology and Toxicology, James Graham Brown Cancer Center, University of Louisville Louisville, KY, USA.
M L SchmidtDepartment of Biochemistry, University of Louisville Louisville, KY, USA.
Eric WaltersDivision of Animal Sciences, National Swine Resource and Research Center, University of Missouri Columbia, MO, USA.
Laurie RundDepartment of Animal Sciences, University of Illinois at Urbana-Champaign Urbana, IL, USA.
Larry SchookDepartment of Animal Sciences, University of Illinois at Urbana-Champaign Urbana, IL, USA.
Geoffrey J ClarkDepartment of Pharmacology and Toxicology, James Graham Brown Cancer Center, University of Louisville Louisville, KY, USA.
University of Louisville · USInstitute of Animal Sciences · CNUniversity of Louisville Hospital · US

Funding

Resource Core for National Swine Resource and Research Center (NSRRC) Years 21-25U42OD011140 · OD · UNIVERSITY OF MISSOURI-COLUMBIA · PI RANDALL S PRATHER · 2012 to 2026
$26.7M
Oncopigs as a better model for human cancerR01CA153132 · NCI · UNIVERSITY OF LOUISVILLE · PI CLARK, GEOFFREY J., RUND, LAURETTA · 2010 to 2013
$1.0M
NCI NIH HHS R01 CA153132NIH HHS U42 OD011140
6 · The paper itself

Abstract

BRCA1 is a breast and ovarian tumor suppressor. Hereditary mutations in BRCA1 result in a predisposition to breast cancer, and BRCA1 expression is down-regulated in ~30% of sporadic cases. The function of BRCA1 remains poorly understood, but it appears to play an important role in DNA repair and the maintenance of genetic stability. Mouse models of BRCA1 deficiency have been developed in an attempt to understand the role of the gene in vivo. However, the subtle nature of BRCA1 function and the well-known discrepancies between human and murine breast cancer biology and genetics may limit the utility of mouse systems in defining the function of BRCA1 in cancer and validating the development of novel therapeutics for breast cancer. In contrast to mice, pig biological systems, and cancer genetics appear to more closely resemble their human counterparts. To determine if BRCA1 inactivation in pig cells promotes their transformation and may serve as a model for the human disease, we developed an immortalized porcine breast cell line and stably inactivated BRCA1 using miRNA. The cell line developed characteristics of breast cancer stem cells and exhibited a transformed phenotype. These results validate the concept of using pigs as a model to study BRCA1 defects in breast cancer and establish the first porcine breast tumor cell line.

Indexed as

BRCA1breast cancermiRNASV40 LTtransformation

Identifiers

PMID26379698
PMCPMC4548227
OpenAlexW1917293425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.